Government Tightens Regulatory Oversight on Medicinal Products with High Alcohol Content
GS2GS3
The Union Health Ministry has revoked licensing exemptions for medicinal products containing high levels of ethyl alcohol, mandating prescription-only sales under Schedule H1 to curb misuse.
In a significant move to strengthen public health safeguards, the Union Health Ministry has tightened the regulatory framework governing medicinal products that contain high concentrations of ethyl alcohol. Historically, certain medicinal formulations, including specific tinctures and tonics, enjoyed exemptions from stringent licensing requirements. However, recognizing the potential for the abuse of these products as substitutes for alcoholic beverages, the government has now removed these exemptions.
Under the updated regulatory regime, these high-alcohol medicinal products will be brought under the purview of Schedule H1 of the Drugs Rules, 1945. This classification is critical as it mandates that such products can only be dispensed against a valid prescription from a registered medical practitioner. Furthermore, pharmacies are now required to maintain detailed records of the sale of these drugs, including the name and address of the prescriber, the patient, and the quantity supplied. This move is aimed at preventing the diversion of medicinal alcohol for non-therapeutic, recreational purposes, which poses severe risks to public health and safety.
Continue reading — free with login
JeetoBharat publishes daily UPSC current affairs mapped to the Mains syllabus. Log in to read full articles.
Log in to read full articleNo credit card required. Free registered users get unlimited access.
This article was curated using AI. While we strive for accuracy, please verify critical facts from official sources.